237 related articles for article (PubMed ID: 23175688)
1. Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia.
Parkin B; Ouillette P; Li Y; Keller J; Lam C; Roulston D; Li C; Shedden K; Malek SN
Blood; 2013 Jan; 121(2):369-77. PubMed ID: 23175688
[TBL] [Abstract][Full Text] [Related]
2. Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.
Parkin B; Ouillette P; Yildiz M; Saiya-Cork K; Shedden K; Malek SN
Clin Cancer Res; 2015 May; 21(9):2045-56. PubMed ID: 25652455
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.
Gronseth CM; McElhone SE; Storer BE; Kroeger KA; Sandhu V; Fero ML; Appelbaum FR; Estey EH; Fang M
Cancer; 2015 Sep; 121(17):2900-8. PubMed ID: 26033747
[TBL] [Abstract][Full Text] [Related]
4. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
Ding L; Ley TJ; Larson DE; Miller CA; Koboldt DC; Welch JS; Ritchey JK; Young MA; Lamprecht T; McLellan MD; McMichael JF; Wallis JW; Lu C; Shen D; Harris CC; Dooling DJ; Fulton RS; Fulton LL; Chen K; Schmidt H; Kalicki-Veizer J; Magrini VJ; Cook L; McGrath SD; Vickery TL; Wendl MC; Heath S; Watson MA; Link DC; Tomasson MH; Shannon WD; Payton JE; Kulkarni S; Westervelt P; Walter MJ; Graubert TA; Mardis ER; Wilson RK; DiPersio JF
Nature; 2012 Jan; 481(7382):506-10. PubMed ID: 22237025
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
Krönke J; Bullinger L; Teleanu V; Tschürtz F; Gaidzik VI; Kühn MW; Rücker FG; Holzmann K; Paschka P; Kapp-Schwörer S; Späth D; Kindler T; Schittenhelm M; Krauter J; Ganser A; Göhring G; Schlegelberger B; Schlenk RF; Döhner H; Döhner K
Blood; 2013 Jul; 122(1):100-8. PubMed ID: 23704090
[TBL] [Abstract][Full Text] [Related]
6. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
7. AML evolution from preleukemia to leukemia and relapse.
Shlush LI; Mitchell A
Best Pract Res Clin Haematol; 2015; 28(2-3):81-9. PubMed ID: 26590763
[TBL] [Abstract][Full Text] [Related]
8. Single-cell mutational profiling enhances the clinical evaluation of AML MRD.
Ediriwickrema A; Aleshin A; Reiter JG; Corces MR; Köhnke T; Stafford M; Liedtke M; Medeiros BC; Majeti R
Blood Adv; 2020 Mar; 4(5):943-952. PubMed ID: 32150611
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
[TBL] [Abstract][Full Text] [Related]
10. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia.
Parkin B; Erba H; Ouillette P; Roulston D; Purkayastha A; Karp J; Talpaz M; Kujawski L; Shakhan S; Li C; Shedden K; Malek SN
Blood; 2010 Dec; 116(23):4958-67. PubMed ID: 20729466
[TBL] [Abstract][Full Text] [Related]
11. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
Flach J; Shumilov E; Wiedemann G; Porret N; Shakhanova I; Bürki S; Legros M; Joncourt R; Pabst T; Bacher U
Hematol Oncol; 2020 Oct; 38(4):425-431. PubMed ID: 32306411
[TBL] [Abstract][Full Text] [Related]
12. Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
Wong TN; Miller CA; Klco JM; Petti A; Demeter R; Helton NM; Li T; Fulton RS; Heath SE; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Welch JS; Graubert TA; Wilson RK; Ley TJ; Link DC
Blood; 2016 Feb; 127(7):893-7. PubMed ID: 26631115
[TBL] [Abstract][Full Text] [Related]
13. Relapsed myelodysplastic clone differs from acute onset clone as shown by X-linked DNA polymorphism patterns in a patient with acute myeloid leukemia.
Jowitt SN; Yin JA; Saunders MJ
Blood; 1993 Jul; 82(2):613-8. PubMed ID: 8101105
[TBL] [Abstract][Full Text] [Related]
14. Clonal evolution of acute myeloid leukemia from diagnosis to relapse.
Vosberg S; Greif PA
Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
[TBL] [Abstract][Full Text] [Related]
16. [Detection of heterogeneity and evolution of subclones in t(8;21) AML by QM-FISH].
Wang YC; Hu LP; Lin D; Li CW; Yuan T; Jia YJ; Tian Z; Tang KJ; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):844-50. PubMed ID: 24171957
[TBL] [Abstract][Full Text] [Related]
17. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
Cui W; Zhang D; Cunningham MT; Tilzer L
Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
[TBL] [Abstract][Full Text] [Related]
18. NF1 inactivation in adult acute myelogenous leukemia.
Parkin B; Ouillette P; Wang Y; Liu Y; Wright W; Roulston D; Purkayastha A; Dressel A; Karp J; Bockenstedt P; Al-Zoubi A; Talpaz M; Kujawski L; Liu Y; Shedden K; Shakhan S; Li C; Erba H; Malek SN
Clin Cancer Res; 2010 Aug; 16(16):4135-47. PubMed ID: 20505189
[TBL] [Abstract][Full Text] [Related]
19. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.
Hackl H; Astanina K; Wieser R
J Hematol Oncol; 2017 Feb; 10(1):51. PubMed ID: 28219393
[TBL] [Abstract][Full Text] [Related]
20. Analysis of acquired genomic copy number aberrations and regions of loss of heterozygosity in acute myelogenous leukemia genomes using Affymetrix SNP 6.0 arrays and supporting software tools.
Ouillette PD; Shedden KA; Li C; Malek SN
Methods Mol Biol; 2013; 973():99-119. PubMed ID: 23412786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
